$5.88
-0.50[-7.84%]
At close: May 15
$5.88
0[0.00%]
PreMarket: 7:17AM EDT
Palisade Bio
(NASDAQ:PALI)Palisade Bio Stock (NASDAQ:PALI), Quotes and News Summary
Palisade Bio Stock (NASDAQ: PALI) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 1.000 / 1.119M |
| Day Range | - - - |
| 52 Wk Range | 3.820 - 36.600 |
| Market Cap | $5.507M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 45 |
| Short Interest | 4.25% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Palisade Bio (PALI) stock?
You can purchase shares of Palisade Bio (NASDAQ: PALI) through any online brokerage.
Who are Palisade Bio's (PALI) competitors?
Other companies in Palisade Bio’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Hepion Pharmaceuticals (NASDAQ:HEPA) and Redhill Biopharma (NASDAQ:RDHL).
What is the target price for Palisade Bio (PALI) stock?
The latest price target for Palisade Bio (NASDAQ: PALI) was reported by Maxim Group on Wednesday, May 1, 2024. The analyst firm set a price target for 22.50 expecting PALI to rise to within 12 months (a possible 282.65% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Palisade Bio (PALI)?
The stock price for Palisade Bio (NASDAQ: PALI) is $5.88 last updated May 15, 2024 at 7:17 AM EDT.
Does Palisade Bio (PALI) pay a dividend?
There are no upcoming dividends for Palisade Bio.
When is Palisade Bio (NASDAQ:PALI) reporting earnings?
Palisade Bio’s Q2 earnings are confirmed for Friday, August 9, 2024.
Is Palisade Bio (PALI) going to split?
There is no upcoming split for Palisade Bio.
What sector and industry does Palisade Bio (PALI) operate in?
Palisade Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.